Use of multiple inflammatory marker tests in primary care: using Clinical Practice Research Datalink to evaluate accuracy
Open Access
- 17 June 2019
- journal article
- research article
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 69 (684) , e462-e469
Abstract
Background: Research comparing C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and plasma viscosity (PV) in primary care is lacking. Clinicians often test multiple inflammatory markers, leading to concerns about overuse.Aim: To compare the diagnostic accuracies of CRP, ESR, and PV, and to evaluate whether measuring two inflammatory markers increases accuracy.Design and setting: Prospective cohort study in UK primary care using the Clinical Practice Research Datalink.Method: The authors compared diagnostic test performance of inflammatory markers, singly and paired, for relevant disease, defined as any infections, autoimmune conditions, or cancers. For each of the three tests (CRP, ESR, and PV), sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under receiver operator curve (AUC) were calculated.Results: Participants comprised 136 961 patients with inflammatory marker testing in 2014; 83 761 (61.2%) had a single inflammatory marker at the index date, and 53 200 (38.8%) had multiple inflammatory markers. For ‘any relevant disease’, small differences were seen between the three tests; AUC ranged from 0.659 to 0.682. CRP had the highest overall AUC, largely because of marginally superior performance in infection (AUC CRP 0.617, versus ESR 0.589, PP<0.001); this is of debatable clinical significance. The NPV for any single inflammatory marker was 94% compared with 94.1% for multiple negative tests.Conclusion: Testing multiple inflammatory markers simultaneously does not increase ability to rule out disease and should generally be avoided. CRP has marginally superior diagnostic accuracy for infections, and is equivalent for autoimmune conditions and cancers, so should generally be the first-line test.Keywords
This publication has 17 references indexed in Scilit:
- ‘I’m fishing really’ — inflammatory marker testing in primary care: a qualitative studyBritish Journal of General Practice, 2016
- ESR can be normal in giant cell arteritis and polymyalgia rheumaticaBMJ, 2012
- Raised inflammatory markersBMJ, 2012
- Concise guidance: diagnosis and management of polymyalgia rheumaticaClinical Medicine, 2010
- Validity of diagnostic coding within the General Practice Research Database: a systematic reviewBritish Journal of General Practice, 2010
- The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patientsBritish Journal of Cancer, 2009
- Erythrocyte Sedimentation Rate, C-Reactive Protein, or Rheumatoid Factor Are Normal at Presentation in 35%–45% of Patients with Rheumatoid Arthritis Seen Between 1980 and 2004: Analyses from Finland and the United StatesThe Journal of Rheumatology, 2009
- Diagnostic Precision of Fecal Calprotectin for Inflammatory Bowel Disease and Colorectal MalignancyAmerican Journal of Gastroenterology, 2007
- Prevalence of a Normal C-Reactive Protein with an Elevated Erythrocyte Sedimentation Rate in Biopsy-Proven Giant Cell ArteritisOphthalmology, 2006
- Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: A prospective follow-up studySeminars in Arthritis and Rheumatism, 2000